AVNS AVANOS MEDICAL, INC.: institutional ownership and insider trading
Over the last 12 months insiders bought $0 and sold $165K on the open market; over its last four quarters it reported revenue of $716M and net income of −$74.4M.
AVNS revenue and earnings
- Quarter ended Mar 31, 2026: revenue $182M, net income $5.10M, EPS 0.11
- Quarter ended Dec 31, 2025: revenue $181M, net income −$1.30M, EPS -0.02
- Quarter ended Sep 30, 2025: revenue $178M, net income −$1.40M, EPS -0.03
- Quarter ended Jun 30, 2025: revenue $175M, net income −$76.8M, EPS -1.66
Recent AVNS insider trades
- Nov 18, 2025: Holbrook Kerr sold 15,000 shares ($165K)
- Aug 13, 2025: Blackford Gary bought 60,000 shares ($660K)
- Mar 6, 2025: Holbrook Kerr sold 7,000 shares ($107K)
5%+ owners
- BlackRock, Inc.: 14.8% (Schedule 13G/A, filed Apr 30, 2025)
- Vanguard Capital Management: 5.0% (Schedule 13G, filed Jul 31, 2026)